Shingles Research Today is a free monthly online journal that collates and summarizes the latest research about Shingles, including details on symptoms, treatment, causes, virus.

Volume 3 (2007), Issue 11 (November)

1. Measuring the gypsum content of C&D debris fines.
   Waste Manag. [Abstract] [Full-text]
2. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study.
   Pain, 132: S52-9. [Abstract] [Full-text]
3. Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria.
   Int J Lab Hematol, 29(6): 426-32. [Abstract] [Full-text]
4. Comparison of the Tzanck test and polymerase chain reaction in the diagnosis of cutaneous herpes simplex and varicella zoster virus infections.
   Int J Dermatol, 46(11): 1177-9. [Abstract] [Full-text]
5. Isotopic response of fungal granuloma following facial herpes zoster infections - report of three cases.
   Int J Dermatol, 46(11): 1141-5. [Abstract] [Full-text]
6. A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.
   J Virol, 81(23): 13200-8. [Abstract] [Full-text]
7. Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.
   J Virol, 81(23): 12758-65. [Abstract] [Full-text]
8. Postherpetic neuralgia: epidemiology, pathophysiology and management.
   Expert Rev Neurother, 7(11): 1581-95. [Abstract] [Full-text]
9. Immunocompetent children account for the majority of complications in childhood herpes zoster.
   J Infect Dis, 196(10): 1455-8. [Abstract] [Full-text]
10. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.
    J Antimicrob Chemother, 60(6): 1316-30. [Abstract] [Full-text]
11. Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.
    Br J Haematol, 139(5): 791-8. [Abstract] [Full-text]
12. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Vaccine, 25(49): 8326-37. [Abstract] [Full-text]
13. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    J Am Acad Dermatol, 57(6): S143-7. [Abstract] [Full-text]
14. Management of herpes zoster and postherpetic neuralgia.
    J Am Acad Dermatol, 57(6): S136-42. [Abstract] [Full-text]
15. Herpes zoster: epidemiology, natural history, and common complications.
    J Am Acad Dermatol, 57(6): S130-5. [Abstract] [Full-text]
16. Varicella vaccination in Europe: are we ready for a universal childhood programme?
    Eur J Pediatr, 167(1): 47-55. [Abstract] [Full-text]

© 2005-2008 Shingles Research Today. All Rights Reserved.